Mwyngil Therapeutics

Mwyngil Therapeutics develops oral small-molecule therapies for metabolic, inflammatory, neuroinflammatory, and renal diseases.

Health and bioEducation

Mwyngil Therapeutics has no funding amount on record yet; its latest known round is Seed (Jun 2026). Recent Funding first saw it on October 2, 2026.

Raise history

1. June 25, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related ai companies

• 11club AI$2.2M · Oct 1, 2026
• PPredictive AIOct 1, 2026
• JJAOPS$260M · Oct 1, 2026
• EestaieOct 1, 2026
• OOpensOct 1, 2026
• KKeepsake Family HistoryOct 1, 2026
• MMetisJeanOct 1, 2026
• UUnveilr AIOct 1, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/mwyngil-therapeutics.